Cover Image

Systemic chemotherapy with epirubicin for treatment of advanced or multifocal hepatocellular carcinoma

The purpose of this retrospective study was to determine the response rate and effect on survival of chemotherapy with epirubicin in non-resectable advanced hepatocellular carcinoma (HCC).

Saved in:
Bibliographic Details
Main Authors: Pohl, Jürgen (Author) , Zuna, Ivan (Author) , Stremmel, Wolfgang (Author) , Rudi, Jochen (Author)
Format: Article (Journal)
Language:English
Published: September 17, 2001
In: Chemotherapy
Year: 2001, Volume: 47, Issue: 5, Pages: 359-365
ISSN:1421-9794
DOI:10.1159/000048544
Online Access:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1159/000048544
Verlag, lizenzpflichtig, Volltext: https://www.karger.com/Article/FullText/48544
Get full text
Author Notes:Jürgen Pohl, Ivan Zuna, Wolfgang Stremmel, Jochen Rudi
Description
Summary:The purpose of this retrospective study was to determine the response rate and effect on survival of chemotherapy with epirubicin in non-resectable advanced hepatocellular carcinoma (HCC).
Item Description:Gesehen am 09.09.2021
Physical Description:Online Resource
ISSN:1421-9794
DOI:10.1159/000048544

Similar Items